Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
CUMBERLAND PHARMACEUTICALS INC. v. FOOD AND DRUG ADMINISTRATION et al
Case Number:
1:12-cv-01842
Court:
Nature of Suit:
Administrative Procedure Act/Review or Appeal of Agency Decision
Judge:
Firms
Companies
Sectors & Industries:
-
January 18, 2013
FDA Defends Approval Of Generic Acetaminophen OD Drug
The U.S. Food and Drug Administration on Friday urged a Washington federal judge to nix Cumberland Pharmaceuticals Inc.'s bid to block a generic version of its acetaminophen-overdose treatment after it changed the formula over safety concerns, saying Cumberland's suit would unfairly extend its monopoly on the drug.
-
November 15, 2012
FDA Approved Possibly Harmful Generic Acetadote, Suit Says
Cumberland Pharmaceuticals Inc. on Tuesday moved to block the U.S. Food and Drug Administration's approval of InnoPharma Inc.'s generic version of Cumberland's acetaminophen-overdose treatment Acetadote, claiming the approval could put potentially harmful versions of the drug on the market.